Viva Biotech Holdings (1873.HK)

HKD 0.89

(-2.2%)

Total Debt Summary of Viva Biotech Holdings

  • Viva Biotech Holdings's latest annual total debt in 2023 was 1.9 Billion CNY , down -32.58% from previous year.
  • Viva Biotech Holdings's latest quarterly total debt in 2024 Q2 was 1.51 Billion CNY , down 0.0% from previous quarter.
  • Viva Biotech Holdings reported annual total debt of 2.82 Billion CNY in 2022, up 6.34% from previous year.
  • Viva Biotech Holdings reported annual total debt of 2.65 Billion CNY in 2021, down -10.6% from previous year.
  • Viva Biotech Holdings reported quarterly total debt of 1.9 Billion CNY for 2023 Q4, down 0.0% from previous quarter.
  • Viva Biotech Holdings reported quarterly total debt of 1.9 Billion CNY for 2023 FY, down -32.58% from previous quarter.

Annual Total Debt Chart of Viva Biotech Holdings (2023 - 2016)

Historical Annual Total Debt of Viva Biotech Holdings (2023 - 2016)

Year Total Debt Total Debt Growth
2023 1.9 Billion CNY -32.58%
2022 2.82 Billion CNY 6.34%
2021 2.65 Billion CNY -10.6%
2020 2.96 Billion CNY 5910.3%
2019 49.4 Million CNY -77.84%
2018 222.96 Million CNY 1391.88%
2017 14.94 Million CNY 326.27%
2016 3.5 Million CNY 0.0%

Peer Total Debt Comparison of Viva Biotech Holdings

Name Total Debt Total Debt Difference
Uni-Bio Science Group Limited 52.86 Million HKD -3500.009%
CK Life Sciences Int'l., (Holdings) Inc. 5.93 Billion HKD 67.911%